Publications by authors named "Martin Cernan"

Claim this Profile
R
Real-World Experience With Venetoclax-Based Therapy in Acute Myeloid Leukemia: Insights From the Czech Republic.
Barbora Dluhošová, Benjamín Víšek, Jan Válka, Martin Čerňan, Ľubomír Minařík

Clin Lymphoma Myeloma Leuk· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS-COV-2-A Report From the EPICOVIDEHA/EPIRESEHA Registry.
Jon Salmanton-García, Francesco Marchesi, Milan Navrátil, Iker Falces-Romero, Maria Ilaria Del Principe

Am J Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A peripherally inserted central catheter offers a secure and reliable method of venous access for patients newly diagnosed with acute promyelocytic leukaemia.
Szotkowski Tomáš, Čerňan Martin, Sopko Ladislav, Hrabovský Štěpán, Procházka Tomáš

J Vasc Access· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report.
Jon Salmanton-García, Francesco Marchesi, Milan Navrátil, Klára Piukovics, Maria Ilaria Del Principe

Am J Hematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis.
Barbora Weinbergerová, Jiří Mayer, Tomáš Kabut, Wolfgang R Sperr, Jana Števková

Br J Haematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry.
Tommaso Francesco Aiello, Jon Salmanton-Garcia, Francesco Marchesi, Barbora Weinbergerova, Andreas Glenthoj

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi, Shaimaa El-Ashwah, Marcio Nucci

Infection· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi, Shaimaa El-Ashwah, Marcio Nucci

Infection· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
Jon Salmanton-García, Francesco Marchesi, Francesca Farina, Barbora Weinbergerová, Federico Itri

EClinicalMedicine· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study.
Ivo Demel, David Skopal, Eliška Šafránková, Petra Rozsívalová, Pavel Jindra

Ann Hematol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry.
Pellegrino Musto, Jon Salmanton-García, Nicola Sgherza, Rui Bergantim, Francesca Farina

Hematol Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemtuzumab ozogamicin plus midostaurin in conjunction with standard intensive therapy for - mutated acute myeloid leukemia patients - Czech center experience.
Barbora Weinbergerová, Martin Čerňan, Tomáš Kabut, Lukáš Semerád, Natália Podstavková

Haematologica· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infectious complications of induction treatment for acute myeloid leukaemia using the "7 + 3" protocol without antibiotic prophylaxis - 15 years of experience of one clinical site.
Martin Cernan, Tomas Szotkowski, Jaromir Hubacek, Milan Kolar, Edgar Faber

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.
Monia Marchetti, Jon Salmanton-García, Shaimaa El-Ashwah, Luisa Verga, Federico Itri, Martin Cernan

Ther Adv Hematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.
Livio Pagano, Jon Salmanton-García, Francesco Marchesi, Ola Blennow, Maria Gomes da Silva, Martin Cernan

Blood· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breakthrough COVID-19 in Vaccinated Patients with Haematologic Malignancies-The First Single-Centre Experience from the Czech Republic.
Martin Čerňan, Tomáš Szotkowski, Jiří Minařík, Milan Kolář, Pavel Sauer

Life (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients - A Czech multicenter experience.
Barbora Weinbergerová, Ivo Demel, Benjamin Víšek, Jan Válka, Martin Čerňan

Hematol Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).
Livio Pagano, Jon Salmanton-García, Francesco Marchesi, Alessandro Busca, Paolo Corradini

J Hematol Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 in 96 Patients With Hematologic Disease: The First Single-center Experience From the Czech Republic.
Martin Čerňan, Tomáš Szotkowski, Aleš Obr, Vojtěch Látal, Antonín Hluší

Clin Lymphoma Myeloma Leuk· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixed-phenotype acute leukemia: state-of-the-art of the diagnosis, classification and treatment.
Martin Cernan, Tomas Szotkowski, Zuzana Pikalova

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis